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The distribution of ~- and fl-subunits of G-proteins was analyzed in membranes of three cell clones which 
are derived from the human neuroblastoma cell line SK-N-SH. The neuroblast-like clone SH-SY5Y shows 
a pattern of G-proteins very similar to that of human brain cortex with high levels of GL, and Go~ but low 
levels of G40~. The intermediate clone SH-IN contains high levels of Go~ and Gi~ and moderate l vels of 
G40~. The non-neuronal clone SH-EP shows high levels of G40~ but lacks Go,. Differentiation of the neuro- 
blast-like clone SH-SY5Y by retinoic acid or nerve growth factor does not change the amount of Gi~ or 
Go~ in the membrane. 
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1. INTRODUCTION 
A family of GTP-binding proteins (G-proteins) 
transduces ignals from membrane-bound recep- 
tors to intracellular effector systems (review [1]). 
Functionally characterized members of this family 
include the stimulatory (Gs) and inhibitory (Gi) 
GTP-binding proteins that couple hormone and 
neurotransmitter r ceptors to the adenylate cyclase 
system. These proteins are heterotrimers composed 
of c~-, ~- and 7-subunits. The ot-subunits vary in 
size from 39 to 52 kDa and can be ADP- 
ribosylated by pertussis toxin and/or cholera tox- 
in. They also contain the GTP-binding site and are 
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endowed with a GTPase activity. Recently porcine 
brain membranes were shown to contain three dif- 
ferent GTP-binding proteins (Gi~, G4oo~, Goc~) that 
can be specifically ADP-ribosylated by pertussis 
toxin [2]. There is increasing evidence that G- 
proteins that are substrates of pertussis toxin, are 
also involved in coupling of receptors to ion chan- 
nels [3] and phospholipase C [4]. 
Human neuroblastoma cells show diverse mor- 
phological and biochemical properties, with 
characteristics of cells derived from the neural 
crest which develop into neurons, Schwann cells 
and melanocytes [5]. The human neuroblastoma 
cell line SK-N-SH contains at least two mor- 
phologically distinct ypes of cells [6]. One cell type 
is neuroblast-like with a small cell body that may 
extend short neuritic processes and is weakly 
substrate adherent. The other cell type is a flat 
non-neuronal cell with strong substrate adhesive- 
ness. Biedler and co-workers [7,8] have selected 
cloned neuronal and non-neuronal cell lines from 
SK-N-SH cells that are relatively stable phenotypi- 
cally although they can interconvert at a very slow 
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rate. Subclones include SH-SY5Y (neuroblast- 
like), SH-IN (intermediate) and SH-EP (non- 
neuronal). In addition to morphological dif- 
ferences these subclones also exhibit dramatic dif- 
ferences in the expression of neurotransmitter 
systems. For example, the/~- and g-opioid recep- 
tor, negatively coupled to adenylate cyclase [9], 
and the muscarinic receptor stimulating phosphati- 
dylinositol turnover [10], are strongly expressed in 
the neuroblast-like clones SH-SY5Y and SH-IN, 
but absent or barely detectable in the non-neuronal 
clone SH-EP [11]. Because of the differences in 
neurotransmitter receptor expression we have in- 
vestigated the composition of G-proteins in sub- 
clones derived from the human neuroblastoma cell 
line SK-N-SH utilizing both pertussis toxin catalyz- 
ed ADP-ribosylation and immunoblot analysis 
with several specific antibodies. 
2. MATERIALS AND METHODS 
2.1. Culture and treatment of human 
neuroblastoma-derived c llclones 
The SK-N-SH cell line and its subclones (SH- 
SY5Y, SH-IN, SH-EP) were provided by Dr June 
L. Biedler of the Sloan-Kettering Institute for 
Cancer Research, Rye, NY. The cells were grown 
at 37°C as monolayer in RPMI 1640 medium sup- 
plemented with 10% fetal calf serum in the 
presence of 100/~g streptomycin/ml and 100 IU 
penicillin/ml. The differentiation of SH-SY5Y 
cells was carried out by culturing the cells (in 80% 
confluency) with either 50 ng/ml nerve growth fac- 
tor (2.5 S form, Sigma, St Louis, MO, USA) or 10 
/zM retinoic acid (Sigma, USA) for 6 days. Medium 
was replaced every 2 days. In the case of retinoic 
acid-treated cells, equal ethanol concentrations 
were present in the control cells. Confluent cells 
were harvested with 0.04% EDTA in CaZ+/Mg 2+ 
free phosphate-buffered saline with mechanical 
agitation. The cell suspension was centrifuged at 
1000 rpm for 7 min and the pellets were collected 
and stored at -75°C.  
2.2. Membrane isolation and ADP-ribosylation 
Membranes were prepared by Dounce 
homogenization of cells and human brain frontal 
lobe cortex as described in [12]. Proteins were 
assayed by the method of Peterson [13] using 
bovine serum albumin as a standard. 25/~g mem- 
brane proteins were ADP-ribosylated in a total 
volume of 50/A containing 100 mM Tris-HCl, pH 
7.8, 1 mM EDTA, 2.5 mM MgClz, 10 mM DTT, 
10 mM thymidine, 1 mM ATP, 0.1 mM GTP, 0.5 
/~g pertussis toxin (List Biological Laboratories, 
Campbell, CA, USA) and 2 ~Ci [ol-3zP]NAD 
(800-1000 Ci/mmol, NEN, Dreieich, FRG). The 
reaction was allowed to proceed for 60 min at 
32°C, stopped by the addition of an equal volume 
of two-fold concentrated sample buffer (0.125 M 
Tris-HC1, pH 6.8, 4°7o (w/v) SDS, 5O7o (w/v) 
2-mercaptoethanol, 20O/o (v/v) glycerol, 0.005O/o 
(w/v) bromophenol blue) and heated for 5 min at 
95°C. 
2.3. SDS-polyacrylamide g l electrophoresis and 
autoradiography 
ADP-ribosylated membrane proteins were 
analyzed on SDS-polyacrylamide gradient gels 
prepared by the method of Laemmli [14]. The slab 
gels (1.5 mm thick) consisted of a 10-12% 
separating el and a 5% stacking gel. Molecular 
mass standards were [14C]methylated proteins 
(Amersham Buchler, Braunschweig, FRG). After 
electrophoresis the gels were dried and exposed to 
Hyperfilm-flmax (Amersham Buchler). 
2.4. Preparation of antibodies against subunits 
of G-proteins 
Antibodies against the GTP-binding site of o~- 
subunits from G-proteins (G, co . . . .  ), against Go~ 
and Ga were prepared as described by Mumby et 
al. [15]. A new antiserum specifically directed 
against he o~-subunit of the 40 kDa G-protein was 
prepared by immunizing rabbits with a synthetic 
peptide derived from the amino acid sequence 
[3-17] of rat cDNA clone AGX13, which has been 
reported to code for G~ [16]. Immunoblot analysis 
of purified G-proteins from bovine brain indicates 
that this antiserum does not recognize G~ but 
reacts with G4o~. The preparation and characteri- 
zation of the antiserum are described elsewhere 
(Lang and Costa, submitted). 
2.5. Immunoblot analysis of SDS-polyacrylamide 
gels 
Membrane proteins and prestained protein 
molecular mass standards (BRL, Eggenstein, 
FRG) were separated on SDS-polyacrylamide gra- 
dient gels and then electrotransferred onto 
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nitrocellulose sheets (BA 85, Schleicher & Schuell, 
Dassel, FRG) for 15 h at 100 V [17]. The 
nitrocellulose sheets were then reacted with the ap- 
propriate dilution of rabbit antiserum followed by 
anti-rabbit IgG alkaline phosphatase conjugate as 
specified by the manufacturers instructions (Pro- 
mega Biotek, Madison, WI, USA). 
3. RESULTS 
Membranes prepared from human brain frontal 
lobe cortex, SK-N-SH, SH-SY5Y, SH-IN and SH- 
EP cells were treated with [oL-32p]NAD in the 
presence or absence of pertussis toxin. Following 
ADP-ribosylation in the presence of pertussis tox- 
in, membrane proteins from human brain frontal 
lobe cortex show two bands of approx. 41 kDa and 
39 kDa on SDS-polyacrylamide gradient gels 
(fig.l). The lower band (Go") is more intensely 
labelled than the upper band (G~). Membranes 
from SH-SY5Y cells also yield two bands of ap- 
prox. 41 kDa (Gicr) and 39 kDa (Go") with com- 
parable labelling intensity, whereas membranes 
from SK-N-SH and SH-IN cells show a higher 
labelling of G~ compared to Go.. Further a third 
band of pertussis toxin substrate (labelled G4o~) 
appears between these two well characterized ce- 
subunits in SK-N-SH and SH-IN membranes. In 
contrast he labelled 39 kDa band is undetectable 
in membranes from non-neural SH-EP cells, in- 
dicating the absence of Go~. 
Immunoblot analyses using rabbit polyclonal 
antibodies against peptides derived from o~- 
subunits of G-proteins were carried out to 
characterize further the pertussis toxin substrates 
in membranes from human brain frontal lobe cor- 
tex and human neuroblastoma-derived c ll clones. 
Using a panreactive antibody directed against the 
highly conserved GTP-binding site present on c~- 
subunits of G-proteins [15], a strong band of ap- 
prox. 39 kDa (Go,) and a weaker band of 41 kDa 
(G~) can be shown in membranes from human 
brain frontal lobe cortex (fig.2A). In membranes 
from SK-N-SH, SH-SY5Y and SH-IN cells the 
same two bands are present, but the lower band 
(Go~) is weaker than the upper band which con- 
tains both G~ and Gaol. In membranes from SH- 
EP cells the lower 39 kDa band recognized by the 
G,  common antiserum is absent, confirming that Go" 
is missing, as suggested by ADP-ribosylation. 
- -  m 
Per fus~ fo~n * + ÷ + ÷ - 
Fig. 1. Pertussis toxin-dependent ADP-ribosylation of cr- 
subunits from G-proteins in membranes from human 
brain frontal lobe cortex, SK-N-SH, SH-SY5Y, SH-IN 
and SH-EP cells. Membranes were treated with 
[o~-32p]NAD in the presence (+) or absence ( - )  of per- 
tussis toxin, and subjected to SDS-PAGE and 
autoradiography. 10/zg membrane proteins were loaded 
per lane. Values on the right indicate the positions of 
molecular mass marker proteins kDa). 
We further used antibodies directed against he 
o~-subunit of Go [15] to confirm the absence of Go" 
in membranes from SH-EP cells. Fig.2B shows the 
presence of high amounts of Go" in membranes 
from human brain frontal lobe cortex, in- 
termediate amounts in membranes from SK-N-SH, 
SH-SY5Y and SH-IN cells and the complete 
absence of Go" in membranes from SH-EP cells. 
The amount of Go" per/~g membrane protein is ap- 
prox. 5-times higher in frontal lobe cortex of 
human brain than in membranes from the 
neuroblast clone SH-SY5Y. 
Antibodies against he ot-subunit of a third per- 
tussis toxin-sensitive G-protein with an in- 
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the SDS-polyacrylamide gradient gels does not 
allow us to separate Gi~ from G40a, we cannot 
determine the relative proportion of these two pro- 
teins in membranes from SH-EP cells. 
Using antibodies against the fl-subunit of G- 
proteins [15] we find that similar amounts of G~ 
per /~g membrane protein are present in mem- 
branes from human brain frontal lobe cortex, SK- 
N-SH, SH-SY5Y, SH-IN, and SH-EP cells 
(fig.2D). Thus the composition of G-protein in 
human neuroblastoma-derived c ll clones differs 
only in the ~-subunits but not in the total amount 
of the common fl-subunit. 
Membranes prepared from SH-SY5Y cells dif- 
ferentiated with retinoic acid or nerve growth fac- 
A. Go, B. fie++ 
t . .  f . .  
U.  C: i1  
L.a ~ Z ~ ~ Z 
26-  
Fig.2. Immunoblot analysis of membrane proteins from 
human brain frontal obe cortex, SK-N-SH, SH-SY5Y, 
SH-IN and SH-EP cells with antibodies pecific for 
G~ . . . . . .  (A), Go~ (B), G40~ (C) and G~ (D). 40/~g mem- 
brane proteins from human brain frontal lobe cortex, 
120/~g from SK-N-SH cells and 80/~g from other cells 
were subjected to SDS-PAGE, transferred to 
nitrocellulose and reaced with Go.common antiserum 
(diluted 1:5000), Go+ antiserum (diluted 1:1000), G4o~ 
antiserum (diluted 1:1000) or G~ antiserum (1:2000). 
Values on the left indicate the position of molecular 
mass marker proteins (kDa). 
68 - -  
t ,3 -  
26-  
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termediate molecular mass of approx. 40 kDa [2] 
were raised in rabbits and were shown to cross- 
react with neither Go,+ nor Gi~ (Lang and Costa, 
submitted). Fig.2C shows the presence of high 
levels of G4o~ in membranes of the cell clone SH- 
EP, intermediate l vels in the membranes of SH- 
IN and SK-N-SH cells and low levels in membranes 
of the cell clone SH-SY5Y and human brain fron- 
tal lobe cortex. Since we have no antibody directed 
specifically against G~ and the resolution power of 
Fig.3. Immunoblot analysis of membrane proteins from 
SH-SY5Y cells and SH-SY5Y cells treated with retinoic 
acid (RA) or nerve growth factor (NGF) with antibodies 
specific for G~ . . . . . .  (A) and Go~ (B). 80/~g membrane 
protein per lane were subjected to SDS-PAGE, trans- 
ferred to nitrocellulose and reacted with G, commo, an- 
tiserum (diluted 1:5000) or Go~ antiserum (diluted 
1:1000). Values on the left indicate the position of 
molecular mass marker proteins (kDa). 
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tor were analyzed by immunoblotting, using both 
the Go, common and Go,~ antiserum. As shown in 
fig.3, treatment of SH-SY5Y cells with retinoic 
acid (RA) or nerve growth factor (NGF) does not 
alter the immunoreactivity of these two antibodies 
in membranes of differentiated cells compared to 
control cells. 
The data presented are representative of two dif- 
ferent batches of cells both for analysis of treated 
and untreated cell membranes. 
4. DISCUSSION 
The three subclones of the human 
neuroblastoma cell line SK-N°SK (SH-SY5Y, SH- 
IN, and SH-EP) are suitable to study the 
phenotypic variation within the neural crest 
lineage, because they are relatively stable and inter- 
convert at a very slow rate [7]. Besides mor- 
phological differences, dramatic biochemical 
differences were observed for these three 
subclones, including expression of neurotransmit- 
ter systems and myc protooncogenes [11]. The dif- 
ferential expression of G-proteins could be one 
mechanism by which a cell can alter coupling of 
membrane receptors to intracellular effector 
systems and thereby responsiveness to extracellular 
signals. In the present work we have analyzed the 
composition of pertussis toxin sensitive G-proteins 
in membranes derived from three subclones of the 
SK-N-SH cell line and find dramatic differences 
between these subclones. 
Membranes from the subclone SH-SY5Y with a 
neuroblastic phenotype show a pattern of G- 
protein c~-subunits very similar to that of mem- 
branes from human frontal lobe cortex: high levels 
of Go~ and Gi, but low levels of G40a. In contrast, 
membranes from the neuroblastoma x glioma cell 
line NG 108-15 show a pattern of c~-subunits from 
G-proteins (high concentration of G4o~) which is 
different from that of mammalian brain cortex 
(unpublished). This suggests that SH-SY5Y cells 
provide a model of central nervous ystem neurons 
more suitable than the commonly used 
neuroblastoma hybrid lines. 
As indicated by the pattern of G-proteins, the 
human neuroblastoma cell line Sk-N-SH with high 
levels of Go~ and G~ and intermediate levels of 
G4o~ represents a mixture of neuroblast-like (SH- 
SY5Y, SH-IN) and non-neuronal (SH-EP) cells. 
The neuroblast-like cell clones SH-SY5Y and SH- 
IN differ in the amount of G4o~ present in their 
membranes, whereas levels of Go~ and G~ are 
almost identical. The neuroblast-like c ll clone SH- 
SYSY and the non-neuronal clone SH-EP differ 
dramatically in the level of Go~ and G4o,~ in their 
membranes. While Go~ is present at high levels in 
SH-SY5Y cells but not detectable in SH-EP cells, 
G40~ is present in low levels in SH-SYSY cells but 
strongly expressed in SH-EP cells. Ross et al. [7] 
have provided evidence that the neuronal and non- 
neuronal cells of SK-N-SH interconvert. Therefore 
during interconversion of neuroblast-like SH- 
SY5Y cells to non-neuronal SH-EP cells the ex- 
pression of Go, must be completely blocked 
whereas the expression of G4oa is strongly en- 
hanced. These findings parallel the fact that 
neurotransmitter systems and the proposed on- 
cogenes c-myc and N-myc are expressed in 
neuroblast-like SH-SY5Y and SH-IN cells but not 
in non-neuronal SH-EP cells [11]. 
Although we cannot provide direct evidence for 
a relationship between changes in expression of G- 
proteins and neurotransmitter systems during in- 
terconversion of these cells, it is likely that expres- 
sion of neurotransmitter systems and cr-subunits of 
G-proteins are under coordinate control that 
parallels observed morphological changes during 
interconversion. An intriguing problem is the ques- 
tion of which G-protein interacts with which recep- 
tor. The simultaneous expression of opioid 
receptors, muscarinic receptors and Go, in the 
neuronal clones suggests a possible interaction. 
However, additional studies are needed to address 
this problem. 
SH-SYSY cells differentiate morphologically 
and biochemically in the presence of low concen- 
trations of retinoic acid. The observed changes 
during differentiation i clude induction of neurite 
outgrowth, partial inhibition of cell growth, in- 
crease in neuron-specific enolase activity and in- 
crease in noradrenaline content [8]. Furthermore, 
differentiation of SH-SY5Y cells by retinoic acid 
increases the opioid receptor density by as much as 
two-fold and enhances opioid-mediated inhibition 
of adenylate cyclase [9,19]. Gierschik et al. [20] 
have shown that differentiation of 3T6-L1 cells 
from fibroblasts to adipocytes is accompanied by 
changes in the level of Gi and Go. Here we show 
that differentiation of SH-SY5Y cells by neither 
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retinoic acid nor nerve growth factor leads to any 
change in the level of Go~ or G~ in the membrane. 
Thus it appears that differentiation of cells does 
not necessarily involve a change in the membrane 
level of G-protein ce-subunits. Such a change may 
be dependent on the cell type and/or the differen- 
tiation agent used. 
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